This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| AIDS (journal) | |
|---|---|
| Title | AIDS |
| Discipline | Medicine |
| Abbreviation | AIDS |
| Publisher | Wolters Kluwer |
| Country | Netherlands |
| Frequency | Biweekly |
| History | 1987–present |
AIDS (journal) is a peer-reviewed medical journal focusing on research related to human immunodeficiency virus and acquired immunodeficiency syndrome. The journal publishes original research, reviews, policy analyses, and clinical studies that intersect with public health, infectious disease, virology, and global health. Articles in the journal have informed practice and policy in contexts ranging from clinical trials to international programs and nongovernmental initiatives.
The journal was established in 1987 during a period marked by high-profile events such as the First International AIDS Conference and the emergence of major research centers including the United States National Institutes of Health, the Wellcome Trust, and the Centers for Disease Control and Prevention. Early editorial leadership included figures associated with institutions like Harvard University, University College London, and the University of California San Francisco. Throughout the 1990s and 2000s the journal operated amid large-scale initiatives such as the President's Emergency Plan for AIDS Relief and the rollout of antiretroviral therapy programs supported by the World Health Organization and the Global Fund. The journal's publishing house transitioned through corporate structures tied to Lippincott Williams & Wilkins and later to global publishing groups connected with Wolters Kluwer.
AIDS covers basic science, clinical research, epidemiology, and health policy related to human immunodeficiency virus and associated comorbidities, engaging with work produced at institutions such as the Institut Pasteur, the Robert Koch Institute, and the Centers for Disease Control and Prevention. The journal routinely features randomized controlled trials from sites affiliated with Johns Hopkins University, Imperial College London, and the University of Cape Town, laboratory studies from groups linked to the Max Planck Society and the National Institutes of Health, and policy analyses involving stakeholders like the Bill & Melinda Gates Foundation, Médecins Sans Frontières, and the Clinton Health Access Initiative. Themes include antiretroviral therapy, pre-exposure prophylaxis trials analogous to those at Fred Hutchinson Cancer Center, vaccine research tied to programs at Scripps Research Institute and the Ragon Institute, mother-to-child transmission interventions practiced at Nelson Mandela School of Medicine, and syndemic interactions studied in collaborations with the London School of Hygiene & Tropical Medicine.
The journal employs a conventional peer review model with an editorial board comprising clinicians and scientists associated with institutions such as Massachusetts General Hospital, Karolinska Institutet, University of Toronto, and McGill University. Manuscripts undergo initial editorial triage followed by external review by experts from centers like Stanford University, Yale University, University of Oxford, and the University of Sydney. Senior editors have affiliations historically linked to organizations such as the International AIDS Society and advisory roles in programs like the Joint United Nations Programme on HIV/AIDS. The staff includes managing editors, statistical editors, and ethics advisors who liaise with institutional review boards at hospitals including Guy's and St Thomas' NHS Foundation Trust and research networks such as the HIV Prevention Trials Network.
AIDS is abstracted and indexed in biomedical databases and citation services associated with large indexing entities such as PubMed, EMBASE, Scopus, and the Web of Science. It is listed in catalogs maintained by national libraries including the British Library and the Library of Congress, and is tracked by metric services used by institutions like Clarivate Analytics and Elsevier for impact evaluation. The journal's inclusion in these services facilitates discoverability by researchers at universities such as Princeton University, Columbia University, and University of Melbourne.
Over decades the journal has contributed to influential debates and guideline development by organizations including the World Health Organization, the United States Food and Drug Administration, and the European Medicines Agency. Papers published in the journal have been cited in clinical guidelines produced by bodies like the British HIV Association and have informed public-health responses at ministries of health in countries such as South Africa, Brazil, and India. The journal's articles have been discussed in academic forums at conferences including the Conference on Retroviruses and Opportunistic Infections and the International AIDS Conference and have influenced funding priorities at philanthropic entities like the Wellcome Trust and the Bill & Melinda Gates Foundation.
Notable contributions include randomized trial reports and multi-center cohort analyses led by investigators from University College London, University of Washington, and MRC Clinical Trials Unit. Special issues have addressed topics coordinated with programs like the President's Emergency Plan for AIDS Relief, thematic collections on prevention technologies with contributions from Fred Hutchinson Cancer Center researchers, and vaccine-focused supplements reflecting collaborations with the Ragon Institute and the International AIDS Vaccine Initiative. Landmark articles have reported outcomes relevant to treatment scale-up in provinces such as KwaZulu-Natal and regions supported by programs like the Global Fund.
The journal operates with a hybrid publication model reflecting practices used by publishers such as Wolters Kluwer and others, offering both subscription access and open-access options for authors funded by agencies including the National Institutes of Health and the European Commission. Author services and licensing follow standards similar to those adopted by organizations like the Committee on Publication Ethics and archiving practices align with repositories used by institutions such as the Wellcome Trust. Submission guidelines reference reporting standards promoted by groups like the International Committee of Medical Journal Editors.
Category:Medical journals